≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_STOMACH_ADENO_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — C16
  • Cancer registry: Morphology ICD-O-3 — 8140|8145
  • Cancer registry: Behaviour codes — 3

1 out of 7 registries used, show all original rules.

1061

4. Check minimum number of events

None

1061

5. Include endpoints

None

1061

6. Filter based on genotype QC (FinnGen only)

1061

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 1061 305 756
Unadjusted period prevalence (%) 0.27 0.10 0.33
Median age at first event (years) 67.71 65.08 68.77

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
998
Matched controls
9980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
570
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
323.0
376
*
A03FA01
ATC
metoclopramide; systemic, rectal
24.7
323.0
562
495
H02AB02
ATC
dexamethasone; systemic
193.6
323.0
344
27
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
+∞
306.5
278
*
L01BC06
ATC
capecitabine; oral
+∞
304.2
276
*
A04AA02
ATC
granisetron; systemic, transdermal
1844.5
292.6
270
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
279.7
255
*
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
2890.4
256.6
237
*
107
Kela drug reimbursment
Pernicious anaemia
40.4
243.9
310
110
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
424.5
236.0
228
7
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
9.6
230.4
678
1798
8145/3-C16.9
ICD-O-3
Carcinoma, diffuse type of stomach, NOS
+∞
225.8
208
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2374.6
219.0
204
*
C16.00
ICD-10 Finland
Cardia
+∞
201.0
186
*
B03BA03
ATC
hydroxocobalamin; parenteral
13.8
197.6
374
414
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
170.8
159
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
163.1
152
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
39.5
155.8
198
62
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
+∞
150.9
141
*
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
+∞
148.7
139
*
JN4BD
NOMESCO Finland
Extensive body CT
16.4
146.0
247
196
C16.23
ICD-10 Finland
Malignant tumor of the corpus ventriculi diffuse carcinoma
+∞
138.8
130
*
Z51.5
ICD-10 Finland
Palliative care
23.0
138.5
205
111
C16.2
ICD-10 Finland
Malignant neoplasm: Body of stomach
+∞
129.0
121
*
A04AA01
ATC
ondansetron; systemic, rectal
33.8
125.2
165
58
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
121.4
114
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
120.3
113
*
C16.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of stomach
+∞
115.9
109
*
N02AA05
ATC
oxycodone; systemic
7.2
115.3
322
622
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
136.1
113.8
120
10
C16.20
ICD-10 Finland
Malignant tumor of the corpus ventriculi without histology
+∞
102.9
97
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
551.9
102.5
100
*
B81
ICPC
Anaemia vit B12/folate deficiency
11.4
102.0
203
219
R4190
NOMESCO Finland
Nutritional therapy
39.8
102.0
129
37
C16.03
ICD-10 Finland
Malignant tumor of cardiac diffuse carcinoma
+∞
93.2
88
*
C16.3
ICD-10 Finland
Malignant neoplasm: Pyloric antrum
+∞
90.0
85
*
C16.39
ICD-10 Finland
Malignant tumor of the antrum ventriculi other or unspecified carcinoma
+∞
90.0
85
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
243.8
88.0
89
*
C16.33
ICD-10 Finland
Malignant tumor of the antrum ventriculi diffuse carcinoma
+∞
86.7
82
*
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
+∞
84.6
80
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.3
83.6
152
133
C16.30
ICD-10 Finland
Malignant tumor of the antrum ventriculi without histology
+∞
83.5
79
*
C16.29
ICD-10 Finland
Malignant tumor of the corpus ventriculi other or unspecified carcinoma
+∞
82.4
78
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
78.1
74
*
JAH01
NOMESCO Finland
Laparoscopy
17.1
72.1
117
77
C16.4
ICD-10 Finland
Malignant neoplasm: Pylorus
+∞
70.7
67
*
L03AA02
ATC
filgrastim; parenteral
154.9
68.9
72
5
TPX10
NOMESCO Finland
Implantation of vascular injection port
16.5
68.1
112
76
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
26.5
67.3
94
39
JN4AD
NOMESCO Finland
Body CT examination
11.6
65.8
127
124
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.8
65.1
138
161
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.7
61.6
329
1160
JN4CD
NOMESCO Finland
Very extensive body CT
18.9
59.8
93
54
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.5
59.7
150
230
A04AD12
ATC
aprepitant; systemic
601.5
58.3
57
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
57.9
55
*
C16.04
ICD-10 Finland
Malignant tumor of cardiac intestinal carcinoma
+∞
57.9
55
*
8145/3-C16.2
ICD-O-3
Carcinoma, diffuse type of body of stomach
+∞
56.8
54
*
JAH00
NOMESCO Finland
Laparotomy
13.8
55.1
97
77
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
54.7
52
*
JDC20
NOMESCO Finland
Partial gastrectomy and Roux-en-Y reconstruction
193.7
53.5
55
*
B01AB05
ATC
enoxaparin; parenteral
3.2
53.5
364
1514
C61
ICD-10 Finland
Malignant neoplasm of prostate
148.1
53.4
56
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
9.8
52.6
110
124
C16.01
ICD-10 Finland
Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma
+∞
52.6
50
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
52.6
50
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
52.6
50
*
C16.34
ICD-10 Finland
Malignant tumor of the antrum ventriculi intestinal carcinoma
+∞
51.5
49
*
8145/3-C16.0
ICD-O-3
Carcinoma, diffuse type of cardia, NOS
+∞
51.5
49
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
49.4
47
*
WX600
NOMESCO Finland
Single shot through catheter
72.5
48.6
55
8
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
19.4
48.3
74
41
8140/3-C16.3
ICD-O-3
Adenocarcinoma, NOS, of gastric antrum
+∞
47.3
45
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
47.3
45
*
WZC30
NOMESCO Finland
Teaching
4.9
46.2
165
388
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
46.2
44
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
46.2
44
*
C16.24
ICD-10 Finland
Malignant tumor of the corpus ventriculi intestinal carcinoma
+∞
44.1
42
*
D74
ICPC
Malignant neoplasm stomach
+∞
44.1
42
*
8145/3-C16.3
ICD-O-3
Carcinoma, diffuse type of gastric antrum
+∞
43.0
41
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.0
42.8
80
72
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
48.7
42.3
51
11
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
+∞
40.9
39
*
C16.21
ICD-10 Finland
Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma
+∞
40.9
39
*
A02BC02
ATC
pantoprazole; systemic
2.5
40.2
658
4368
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
42.9
39.7
49
12
UJD02
NOMESCO Finland
Gastroscopy
5.9
39.2
116
218
6322
FHL
Gastrectomy (including Roux-Y)
208.0
39.1
40
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
23.7
37.8
54
24
L01BC53
ATC
tegafur, combinations; systemic
+∞
37.7
36
*
C16
ICD-10 Finland
Malignant neoplasm of stomach
+∞
37.7
36
*
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
26.0
37.5
52
21
JDC10
NOMESCO Finland
Partial gastrectomy and gastrojejunostomy
380.8
37.3
37
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
37.8
37.2
47
13
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
104.1
37.0
40
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
36.7
35
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
370.0
36.2
36
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
191.8
36.0
37
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
34.9
260
1096
WX402
NOMESCO Finland
General anaesthesia
3.8
33.8
158
473
UJC12
NOMESCO Finland
Flexible oesophagoscopy
32.8
33.7
44
14
TPH07
NOMESCO Finland
Cathetrisation of artery
3.8
33.2
155
463
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
32.5
31
*
C16.5
ICD-10 Finland
Malignant neoplasm: Lesser curvature of stomach, unspecified
+∞
32.5
31
*
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
117.2
31.9
34
*
B01AB10
ATC
tinzaparin; parenteral
6.2
31.7
88
152
JKA20
NOMESCO Finland
Cholecystectomy
6.8
31.2
81
128
WW500
NOMESCO Finland
Blood transfusion
8.5
31.0
69
86
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
88.0
30.9
34
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
30.5
134
379
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
30.4
29
*
C16.31
ICD-10 Finland
Malignant tumor of the antrum ventriculi early diffuse gastric carcinoma
+∞
30.4
29
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
85.3
29.9
33
*
R11
ICD-10 Finland
Nausea and vomiting
3.9
29.4
130
369
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.6
29.4
78
127
116
Kela drug reimbursment
Prostate cancer
+∞
29.3
28
*
8140/3-C16.2
ICD-O-3
Adenocarcinoma, NOS, of body of stomach
+∞
28.3
27
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
28.3
27
*
ZX120
NOMESCO Finland
Intravenous
3.8
27.5
124
358
A06AH03
ATC
naloxegol; oral
55.0
27.3
32
6
JCC10
NOMESCO Finland
Transthoracic partial oesophagectomy without interposition
+∞
27.2
26
*
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
63.9
27.1
31
5
XX3DW
NOMESCO Finland
Time consuming IT work
5.3
26.7
84
169
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
12.5
26.7
48
40
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
26.2
239
1109
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
19.3
25.8
39
21
JMA10
NOMESCO Finland
Transabdominal total splenectomy
39.9
25.0
31
8
WF002
NOMESCO Finland
Radical radiotherapy
133.3
24.7
26
*
JDW97
NOMESCO Finland
Other laparoscopic operation on stomach or duodenum
+∞
24.0
23
*
JFF00
NOMESCO Finland
Catheter enterostomy
+∞
24.0
23
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
23.0
22
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
23.0
22
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
122.8
22.7
24
*
R18
ICD-10 Finland
Ascites
9.2
22.0
46
52
384
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
+∞
21.9
21
*
C16.02
ICD-10 Finland
Malignant tumor of cardiac early intestinal gastric carcinoma
+∞
21.9
21
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
31.9
21.6
28
9
B03BA02
ATC
cyanocobalamin tannin complex; parenteral
12.8
21.0
37
30
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
20.9
20
*
A79
ICPC
Malignancy NOS
112.3
20.6
22
*
A98
ICPC
Health maint/preventive medicine
0.5
20.0
535
6838
C16.6
ICD-10 Finland
Malignant neoplasm: Greater curvature of stomach, unspecified
+∞
19.9
19
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
19.9
19
*
JDD96
NOMESCO Finland
Total gastrectomy with other reconstruction
+∞
19.9
19
*
115
Kela drug reimbursment
Breast cancer
+∞
19.9
19
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
19.7
159
681
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
101.9
18.6
20
*
JDE00
NOMESCO Finland
Gastrojejunostomy
193.4
18.6
19
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
9.1
18.3
38
43
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.1
18.2
105
365
K22.2
ICD-10 Finland
Oesophageal obstruction
10.3
18.0
35
35
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
17.8
17
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
17.8
17
*
376
Kela drug reimbursment
Cyanocobalamin
+∞
17.8
17
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.1
17.6
70
180
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
7.1
17.6
43
63
K92.0
ICD-10 Finland
Haematemesis
4.6
17.6
62
142
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
5.4
17.3
52
100
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
10.6
16.8
32
31
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
16.7
16
*
D00.2
ICD-10 Finland
Carcinoma in situ: Stomach
+∞
16.7
16
*
C16.19
ICD-10 Finland
Malignant tumor of the fundus ventriculi other or unspecified carcinoma
+∞
16.7
16
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
16.7
16
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
16.7
16
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
16.7
16
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
16.7
16
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
16.7
16
*
1514C
ICD-9 Finland
Malignant neoplasm of stomach, Body of stomach[MAHASYÖPÄ, CORPORIS DIFFUUSI KARSINOOMA]
+∞
16.7
16
*
JDC97
NOMESCO Finland
Laparoscopic partial gastrectomy with other reconstruction
+∞
16.7
16
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
16.7
402
2711
NK6AN
NOMESCO Finland
Total body bone isotope imaging
91.6
16.6
18
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
28.1
16.5
22
8
K92.1
ICD-10 Finland
Melaena
3.2
16.5
92
309
R13
ICD-10 Finland
Dysphagia
3.1
16.3
92
313
L02AE02
ATC
leuprorelin; implant, parenteral
34.0
15.8
20
6
JDC11
NOMESCO Finland
Laparoscopic partial gastrectomy and gastrojejunostomy
+∞
15.7
15
*
T91
ICPC
Vitamin/nutritional deficiency
11.5
15.3
28
25
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.6
15.3
69
199
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
14.6
14
*
C16.32
ICD-10 Finland
Malignant tumor of the antrum ventriculi early intestinal gastric carcinoma
+∞
14.6
14
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
14.6
14
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
81.3
14.6
16
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
6.2
14.3
38
63
RD210
NOMESCO Finland
NA
9.0
14.0
29
33
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
13.8
185
997
B01AB04
ATC
dalteparin; parenteral
3.6
13.8
63
184
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.3
13.8
28
31
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
76.2
13.6
15
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.6
13
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.6
13
*
JFF01
NOMESCO Finland
Laparoscopic catheter enterostomy
+∞
13.6
13
*
C10AA05
ATC
atorvastatin; oral
0.5
13.5
180
2887
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
13.3
390
2739
TPX15
NOMESCO Finland
Removal of vascular injection port
22.9
12.9
18
8
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
7.6
12.7
29
39
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
12.6
143
717
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
12.5
144
725
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
12.5
12
*
C16.10
ICD-10 Finland
Malignant tumor of the fundus ventriculi without histology
+∞
12.5
12
*
C16.13
ICD-10 Finland
Malignant tumor of the fundus ventriculi diffuse carcinoma
+∞
12.5
12
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
12.5
12
*
C16.22
ICD-10 Finland
Malignant tumor of the corpus ventriculi early intestinal gastric carcinoma
+∞
12.5
12
*
C16.1
ICD-10 Finland
Malignant neoplasm: Fundus of stomach
+∞
12.5
12
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
12.4
117
539
N02AA01
ATC
morphine; systemic, rectal
8.1
12.4
27
34
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
12.3
132
643
K91.1
ICD-10 Finland
Postgastric surgery syndromes
38.0
12.2
15
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.9
12.0
29
43
J01MA12
ATC
levofloxacin; systemic
1.9
11.8
186
1064
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
65.7
11.6
13
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
65.7
11.6
13
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
11.6
278
1823
ZX121
NOMESCO Finland
Central venous catheter
23.2
11.6
16
7
8140/3-C16.4
ICD-O-3
Adenocarcinoma, NOS, of pylorus
+∞
11.5
11
*
C15.1
ICD-10 Finland
Malignant neoplasm: Thoracic part of oesophagus
+∞
11.5
11
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
11.5
11
*
Y77
ICPC
Malignant neoplasm prostate
+∞
11.5
11
*
C15.2
ICD-10 Finland
Malignant neoplasm: Abdominal part of oesophagus
+∞
11.5
11
*
I10
ICD-10 Finland
Essential (primary) hypertension
0.6
11.2
372
4849
Z31.5
ICD-10 Finland
Genetic counselling
5.2
11.0
33
65
R50.9
ICD-10 Finland
Fever, unspecified
2.1
10.9
129
660
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
12.1
10.9
19
16
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.4
10.8
43
1042
A02BC05
ATC
esomeprazole; systemic
1.6
10.6
341
2416
SPAT1053
SPAT
Memory test
0.4
10.6
53
1175
V03AF03
ATC
calcium folinate; systemic
60.6
10.6
12
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.1
10.6
25
36
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
14.4
10.5
17
12
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
111.1
10.4
11
*
6321
FHL
Subtotal gastrectomy (also includes oment and spleen removal)
+∞
10.4
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
L01BC04
ATC
carmofur; oral
+∞
10.4
10
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
10.4
10
*
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
32.9
10.3
13
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.7
10.2
28
50
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
40.5
10.0
12
*
N06DX01
ATC
memantine; oral
0.3
10.0
18
624
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
6.4
9.9
25
40
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
20.2
9.8
14
7
WX704
NOMESCO Finland
Intubation
2.7
9.8
65
247
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.1
9.8
37
93
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
6.6
9.8
24
37
JFC00
NOMESCO Finland
Entero-enterostomy
55.5
9.7
11
*
A02BC03
ATC
lansoprazole; oral
1.6
9.6
282
1944
WX002
NOMESCO Finland
Sedation and analgesia
1.8
9.5
166
979
I50.9
ICD-10 Finland
Heart failure, unspecified
0.5
9.4
84
1534
ZXC86
NOMESCO Finland
Use of endoscopic device
17.7
9.4
14
8
JCC00
NOMESCO Finland
Transhiatal partial oesophagectomy without interposition
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
JDH35
NOMESCO Finland
Endoscopic insertion of duodenal stent
+∞
9.4
9
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.4
9
*
15199
ICD-8 Finland
Malignant neoplasm of stomach, Part unspecified
+∞
9.4
9
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
9.4
9
*
TJA10
NOMESCO Finland
Laparocentesis
+∞
9.4
9
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.3
9.4
45
139
A02BX02
ATC
sucralfate; oral
2.7
9.4
62
235
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.0
9.3
22
32
R4110
NOMESCO Finland
Physiotherapy
1.7
9.2
212
1362
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
9.2
68
276
P20
ICPC
Memory disturbance
0.4
8.9
44
983
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.7
8.8
37
103
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
8.8
80
361
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.3
8.8
15
533
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
8.8
125
687
N06DA02
ATC
donepezil; oral
0.2
8.7
12
483
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
8.7
67
280
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
50.4
8.7
10
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
8.3
8.6
18
22
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.8
8.6
27
57
JFB30
NOMESCO Finland
Right hemicolectomy
11.7
8.6
15
13
RD160
NOMESCO Finland
NA
27.8
8.5
11
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.0
8.5
46
156
HAC20
NOMESCO Finland
Total mastectomy
90.8
8.4
9
*
M01AH05
ATC
etoricoxib; oral
0.6
8.4
238
3270
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.3
8
*
8145/3-C16.4
ICD-O-3
Carcinoma, diffuse type of pylorus
+∞
8.3
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
8.3
8
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
8.3
8
*
C16.14
ICD-10 Finland
Malignant tumor of the fundus ventriculi intestinal carcinoma
+∞
8.3
8
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
8.3
8
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
8.3
8
*
1CD02
NOMESCO Finland
NA
+∞
8.3
8
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
8.3
8
*
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
5.6
8.3
23
42
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.1
8.0
15
15
HAB40
NOMESCO Finland
Wedge excision of mammary gland
22.2
8.0
11
5
-50
ICPC
Medication/prescr/renewal
2.8
8.0
48
175
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
7.8
20
586
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
7.8
142
2154
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.6
7.7
25
55
L02BA01
ATC
tamoxifen; oral
45.3
7.7
9
*
I50.0
ICD-10 Finland
Congestive heart failure
0.4
7.7
36
819
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
7.6
7
356
JFF10
NOMESCO Finland
Loop enterostomy
25.2
7.6
10
*
Z98.8
ICD-10 Finland
Other specified postsurgical states
5.2
7.6
22
43
N05AX08
ATC
risperidone; systemic
0.4
7.6
24
641
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.7
7.5
24
52
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
7.4
98
1612
K56.7
ICD-10 Finland
Ileus, unspecified
4.3
7.4
26
62
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.6
7.4
155
2281
C09CA01
ATC
losartan; oral
0.6
7.3
96
1582
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.5
7.3
50
999
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
7.3
7
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
7.3
7
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
7.3
7
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
7.3
7
*
C15.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oesophagus
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
+∞
7.3
7
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
7.3
7
*
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.5
7.3
52
1022
PJA10
NOMESCO Finland
Exploration of lymph nodes
15.9
7.2
11
7
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
30.2
7.2
9
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.6
7.1
167
2404
N05CF01
ATC
zopiclone; oral
1.5
7.1
306
2282
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.7
7.0
29
81
ZX112
NOMESCO Finland
Subcutaneous
7.0
7.0
16
23
C08CA01
ATC
amlodipine; oral
0.7
6.9
197
2723
KA1FN
NOMESCO Finland
Isotope renography
11.0
6.8
12
11
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
40.3
6.8
8
*
XF612
NOMESCO Finland
Measurement of central venous pressure
40.3
6.8
8
*
L02BG04
ATC
letrozole; oral
22.7
6.7
9
*
Z53.0
ICD-10 Finland
Procedure not carried out because of contraindication
22.7
6.7
9
*
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
12.3
6.6
11
9
6318
FHL
Resection (2/3) and gastrojejunostomy (including Roux-Y)
12.3
6.6
11
9
-55
ICPC
Local injection/infiltration
10.1
6.5
12
12
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
6.5
241
1733
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
70.3
6.4
7
*
C50.99
ICD-10 Finland
Breast, unspecified
70.3
6.4
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
70.3
6.4
7
*
WF001
NOMESCO Finland
Preoperative radiotherapy
70.3
6.4
7
*
K91.8
ICD-10 Finland
Other postprocedural disorders of digestive system, not elsewhere classified
70.3
6.4
7
*
A06AD11
ATC
lactulose; oral
1.6
6.4
172
1145
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.7
6.4
41
154
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.4
6.4
32
711
C78.5
ICD-10 Finland
Secondary malignant neoplasm of large intestine and rectum
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
+∞
6.3
6
*
WGA10
NOMESCO Finland
Measurement of pain intensity
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
1510E
ICD-9 Finland
Malignant neoplasm of stomach, Cardia[MAHASYÖPÄ,KARDIA,MUU TARK MÄÄR CA]
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
JD003
NOMESCO Finland
Adjuvant radiotherapy of gastric or duodenal tumor
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
JDC00
NOMESCO Finland
Partial gastrectomy and gastroduodenostomy
+∞
6.3
6
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
6.3
6
*
JDC96
NOMESCO Finland
Partial gastrectomy with other reconstruction
+∞
6.3
6
*
1505A
ICD-9 Finland
Malignant neoplasm of oesophagus, Lower third of oesophagus
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
26.8
6.2
8
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
6.3
6.2
15
24
N05BA06
ATC
lorazepam; systemic, sublingual
2.2
6.2
56
257
M05BX04
ATC
denosumab; parenteral
2.7
6.1
38
143
I50.1
ICD-10 Finland
Left ventricular failure
0.4
6.1
18
494
JWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gastroenterological surgery
12.6
6.1
10
8
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
10.1
6.0
11
11
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
10.1
6.0
11
11
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.6
6.0
16
29
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.6
6.0
16
29
K83.0
ICD-10 Finland
Cholangitis
5.6
6.0
16
29

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
247
143
22.21
312.12
6.0
1.8
u/ml
663.9
98.7
0.56
231
111
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
433
387
18.21
307.65
6.5
1.4
ug/l
27.9
3.7
2.65
406
300
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
173
78
26.31
241.31
4.7
1.6
u/ml
153.1
69.6
0.80
164
71
(4035726)
186
175
12.68
176.64
1.7
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
272
543
6.39
136.56
3.3
1.9
g/l
0.2
0.2
0.28
264
480
(40768797) Stomach Pathology biopsy report
346
888
5.30
131.10
1.9
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
72
0
+∞
75.96
1.1
0.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
293
1037
3.52
66.99
3.7
2.5
mmol/l
0.8
0.8
1.44
279
941
(3024561) Albumin [Mass/volume] in Serum or Plasma
530
3029
2.50
46.31
10.5
3.6
g/l
32.2
34.9
21.87
514
2756
(3002256) Pathology report gross observation
146
445
3.64
40.67
1.6
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
552
3387
2.31
38.88
15.2
3.7
umol/l
11.7
12.9
1.04
539
3153
(3003458) Phosphate [Moles/volume] in Serum or Plasma
225
936
2.78
36.77
4.4
4.8
mmol/l
1.0
1.0
0.38
217
841
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
398
2166
2.34
36.71
3.3
2.2
u/l
67.3
58.0
1.45
372
1974
(3044640) Blood type and Crossmatch panel - Blood
366
1952
2.34
35.08
3.9
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
491
6933
0.46
33.91
3.9
5.3
mmol/l
2.4
2.6
2.89
434
6264
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
481
6736
0.48
30.24
3.5
4.7
mmol/l
4.3
4.4
0.87
428
6118
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
465
6584
0.48
30.09
6.3
6.5
mmol/mol
41.3
41.2
0.12
417
6009
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
475
6662
0.48
29.63
3.4
4.7
mmol/l
1.5
1.4
2.76
415
6001
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
167
695
2.66
26.70
4.1
2.3
umol/l
10.2
10.1
0.02
150
605
(3000570) Elastase.pancreatic [Mass/mass] in Stool
70
170
4.34
26.55
1.7
1.3
ug/g
251.6
292.7
1.07
61
96
(40768804) Tissue Pathology biopsy report
332
1892
2.10
25.54
2.9
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
364
2154
2.05
25.23
5.1
4.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
453
2934
1.95
23.96
5.8
3.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
472
6439
0.52
23.73
3.3
4.2
mmol/l
1.2
1.3
2.04
414
5749
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
449
6212
0.52
23.48
4.2
4.3
mu/l
2.0
2.2
0.67
401
5529
(3032080) INR in Blood by Coagulation assay
475
3146
1.92
23.32
9.4
11.6
inr
1.3
1.4
3.25
139
862
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
141
576
2.67
23.26
5.0
2.1
u/l
37.2
32.9
0.61
130
465
(3022948) Iron [Moles/volume] in Serum or Plasma
227
1155
2.23
23.04
2.4
2.3
umol/l
10.8
12.6
2.82
212
1036
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
274
1510
2.10
22.64
3.5
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
522
6840
0.53
21.92
4.1
4.9
mmol/l
6.1
6.1
0.37
468
6105
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
126
502
2.71
21.79
1.5
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
515
3567
1.86
21.45
15.6
6.0
e9/l
4.1
4.5
0.94
469
3064
(3015377) Calcium [Moles/volume] in Serum or Plasma
362
2253
1.92
20.92
6.6
2.0
mmol/l
2.3
2.3
5.54
347
1843
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
248
1355
2.08
20.76
7.4
2.3
mmol/l
2.5
2.4
1.90
240
1147
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
327
1974
1.95
20.66
5.3
2.6
u/l
43.2
36.0
0.86
321
1867
(3004789) Transferrin [Mass/volume] in Serum or Plasma
203
1043
2.17
19.87
2.3
2.4
g/l
2.5
2.2
6.05
189
944
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
320
1960
1.91
19.10
2.6
2.2
mg/l
3.4
3.0
1.32
293
1626
(4281824)
23
26
9.02
18.59
1.1
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
140
640
2.37
18.03
4.3
6.1
mmol/l
8.2
11.4
5.23
130
594
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
188
973
2.13
17.93
2.3
2.5
%
17.9
22.8
3.96
157
809
(3000963) Hemoglobin [Mass/volume] in Blood
619
7570
0.56
17.84
45.5
21.0
g/l
118.6
135.4
113.77
601
7359
(3026361) Erythrocytes [#/volume] in Blood
619
7569
0.56
17.81
45.3
20.9
e12/l
4.1
4.5
62.21
591
7238
(3035941) MCH [Entitic mass]
619
7568
0.56
17.78
45.1
20.8
pg
29.7
30.5
14.95
603
7362
(3024731) MCV [Entitic volume]
619
7567
0.56
17.76
45.1
20.9
fl
90.8
91.7
3.77
603
7359
(3007461) Platelets [#/volume] in Blood
619
7567
0.56
17.76
45.3
20.9
e9/l
264.8
236.7
13.56
595
7268
(3010813) Leukocytes [#/volume] in Blood
620
7572
0.56
17.65
45.2
20.9
e9/l
7.5
6.9
1.53
590
7245
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
75
255
3.09
17.27
2.1
2.7
u/ml
0.4
0.4
0.00
38
156
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
91
371
2.59
14.94
11.4
8.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
364
4961
0.59
13.97
3.5
3.5
pmol/l
14.6
15.0
2.61
326
4414
(3004809) Band form neutrophils/100 leukocytes in Blood
33
76
4.45
13.40
1.7
3.4
%
1.7
1.9
0.09
26
56
(3023103) Potassium [Moles/volume] in Serum or Plasma
616
7342
0.62
12.85
36.3
17.8
mmol/l
4.0
4.0
5.79
594
7074
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
608
7263
0.62
12.72
19.4
9.1
u/l
30.4
25.8
0.73
588
6888
(3019550) Sodium [Moles/volume] in Serum or Plasma
616
7326
0.62
12.49
36.2
17.7
mmol/l
138.8
139.7
14.38
596
7070
(40761511) CBC panel - Blood by Automated count
590
7064
0.63
12.02
29.6
14.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
135
728
1.98
11.27
10.8
6.5
g/l
113.4
121.0
4.37
130
699
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
465
3567
1.54
10.48
9.2
5.3
mmol/l
1.2
1.2
5.48
382
2986
(3012516) Albumin [Mass/volume] in Urine
149
2416
0.55
10.11
2.8
3.2
mg/l
509.1
240.4
0.26
95
1565
(3003694) ABO and Rh group [Type] in Blood
236
1557
1.66
10.02
1.3
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
227
3285
0.61
9.93
2.3
2.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
233
1541
1.66
9.77
10.9
4.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
165
2569
0.58
9.56
3.3
4.0
mg/mmol
13.7
8.4
0.54
107
1665
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
259
3608
0.63
9.52
3.8
3.9
ug/l
2.2
2.2
0.03
228
3193
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
198
2926
0.60
9.30
3.5
3.8
%
23.5
24.3
0.29
93
1420
(3018418) pH of Serum or Plasma
292
2063
1.57
9.28
5.1
3.1
ph
7.4
7.4
0.36
72
357
(3000991) Gas panel - Venous blood
113
620
1.92
8.94
11.2
6.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
12
15
8.08
8.87
1.8
2.1
e6/l
726.0
104190.5
—
5
10
(3016502) Oxygen saturation in Arterial blood
138
809
1.81
8.87
10.6
6.1
%
96.4
94.8
3.44
132
776
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
419
3232
1.49
8.74
8.2
5.0
mmol/l
1.2
1.2
4.26
400
2843
(3009508) Creatinine [Moles/volume] in Urine
162
2473
0.59
8.53
2.7
3.2
mmol/l
8.2
7.7
0.79
125
2045
(3003396) Base excess in Arterial blood by calculation
148
897
1.76
8.49
10.0
6.0
mmol/l
1.3
1.4
0.07
121
673
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
49
196
2.57
8.42
1.5
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
534
6335
0.68
8.40
32.9
13.6
ml/min/173m2
81.7
73.6
16.07
475
5104
(1761868) Lipid panel - Serum or Plasma
127
2058
0.57
8.37
2.7
3.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
163
1020
1.71
8.34
1.9
1.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
90
474
1.98
8.02
2.2
3.7
%
1.2
0.8
0.82
42
114
(3027801) Oxygen [Partial pressure] in Arterial blood
146
898
1.73
7.94
10.3
5.9
kpa
12.7
11.3
2.82
139
851
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
146
898
1.73
7.94
10.3
5.9
kpa
5.1
5.1
0.27
139
851
(3026493) Urate [Moles/volume] in Serum or Plasma
119
1933
0.57
7.85
2.1
2.5
umol/l
3349.3
8286.8
0.86
104
1624
(3001122) Ferritin [Mass/volume] in Serum or Plasma
359
2730
1.48
7.84
3.4
2.7
ug/l
81.8
150.1
11.08
337
2462
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
107
1789
0.55
7.83
1.7
1.6
mmol/l
1.2
1.4
2.41
87
1475
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
98
539
1.90
7.70
4.9
3.3
mmol/l
1.2
1.2
0.47
88
458
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
128
2025
0.58
7.62
2.4
2.7
ug/l
0.8
0.8
0.11
95
1389
(3013707) Erythrocyte sedimentation rate by Westergren method
419
5134
0.70
7.42
3.6
3.9
mm/h
14.7
13.2
1.21
378
4660
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
45
973
0.44
7.10
1.3
1.2
u/ml
81.7
14.7
0.44
21
354
(3030905) Polymorphonuclear cells [#/volume] in Blood
30
103
2.97
6.89
2.4
2.8
e9/l
4.4
4.8
0.28
30
103
(40768806) Pleura Pathology biopsy report
22
62
3.60
6.89
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
80
427
1.94
6.88
2.2
3.7
%
0.6
0.5
0.18
26
85
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
87
479
1.89
6.83
1.7
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
17
6.53
6.78
1.0
2.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
476
5658
0.71
6.78
41.3
19.0
g/l
326.9
332.3
26.96
467
5574
(3021440) Promyelocytes/100 leukocytes in Blood
83
453
1.90
6.69
2.3
3.8
%
0.0
0.1
0.65
37
104
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
17
41
4.20
6.56
1.1
1.3
ug/l
21.5
14.8
0.49
17
41
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
30
107
2.86
6.46
3.3
3.0
%
59.2
60.5
0.17
30
107
(3033799) Differential panel - Peritoneal fluid
10
15
6.72
6.32
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
512
5951
0.73
5.93
34.2
15.8
%
35.4
39.3
16.35
323
3721
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
32
124
2.63
5.92
1.3
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
168
1155
1.54
5.79
2.0
1.8
s
31.3
30.1
0.60
168
1115
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
68
369
1.90
5.61
15.2
7.5
mmol/l
24.3
24.4
0.09
68
329
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
30
4.37
5.30
1.2
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
49
242
2.07
5.28
5.6
5.4
mmol/l
1.5
1.3
0.34
42
215
(3013826) Glucose [Moles/volume] in Serum or Plasma
503
4261
1.34
5.26
7.8
4.3
mmol/l
6.6
6.9
2.86
485
3981
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
611
6860
0.74
5.25
31.4
14.6
mg/l
38.4
26.3
13.14
561
5423
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
65
3.12
5.08
1.4
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
50
922
0.52
4.99
2.9
5.0
%
34.8
32.2
0.96
36
592
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
183
2464
0.69
4.95
1.9
2.1
u/l
646.8
248.4
0.54
165
2292
(3025159) Blasts/100 leukocytes in Blood
74
430
1.77
4.94
2.4
3.8
%
0.0
1.0
0.50
30
91
(3027945) Reticulocytes/100 erythrocytes in Blood
139
960
1.52
4.68
1.8
2.0
%
1.6
1.8
0.71
124
839
(3018572) Chloride [Moles/volume] in Blood
36
167
2.20
4.57
6.6
6.0
mmol/l
106.1
105.9
0.10
31
151
(3039000) Anion gap in Blood
36
167
2.20
4.57
6.6
6.0
mmol/l
10.6
11.4
0.64
31
151
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
59
1009
0.56
4.57
1.3
1.3
iu/ml
15.9
34.8
3.90
16
321
(3002582) Erythrocytes [#/volume] in Urine
277
2191
1.36
4.40
3.2
3.0
e6/l
41.7
95.9
1.01
222
1696
(3006653) Thiamine [Moles/volume] in Blood
13
35
3.75
4.37
1.2
1.2
nmol/l
115.2
135.6
1.31
13
35
(3002032) Base excess in Venous blood by calculation
113
760
1.54
4.30
3.7
3.0
mmol/l
2.5
2.1
0.39
84
596
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
593
5240
1.30
4.21
16.5
5.2
u/l
111.8
77.3
12.85
574
4787
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
62
2.94
4.18
1.3
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
13
6.97
4.16
2.2
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
44
795
0.53
4.13
1.3
1.3
titre
400.0
481.9
0.23
11
193
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
108
727
1.54
4.10
2.2
2.7
u/l
216.0
241.7
2.49
101
671
(3026782) Osmolality of Urine
193
1455
1.40
4.10
3.1
2.5
mosm/kgh2o
552.1
554.1
0.04
174
1205
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
63
2.89
4.07
1.3
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
63
2.89
4.07
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
206
2638
0.73
4.02
2.8
3.2
ng/l
2133.6
1855.1
0.29
189
2260
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
64
2.84
3.97
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
64
2.84
3.97
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
64
2.84
3.97
1.3
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
104
700
1.54
3.96
2.0
2.2
e9/l
58.3
67.5
1.91
81
553
(3010421) pH of Blood
39
199
2.00
3.91
2.2
4.6
ph
7.4
7.4
0.08
32
159
(3030467) Casts [#/volume] in Urine by Automated count
247
1961
1.34
3.78
3.1
3.0
e6/l
1.2
0.4
0.98
193
1487
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
42
223
1.92
3.77
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
173
1301
1.39
3.72
3.4
3.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
202
0.24
3.70
1.6
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
33
163
2.06
3.63
2.4
4.9
mmol/l
3.1
2.7
0.42
24
100
(42870588) Differential panel, method unspecified - Blood
265
2138
1.32
3.61
3.8
5.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
55
327
1.72
3.46
5.8
4.2
%
0.9
0.9
0.27
50
310
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
56
338
1.69
3.35
5.7
4.1
%
1.7
1.7
0.01
51
321
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
657
0.55
3.31
1.5
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
353
2994
1.27
3.22
4.1
5.6
%
9.3
8.9
1.13
337
2744
(3021960) Folate [Moles/volume] in Serum or Plasma
239
1930
1.31
3.20
1.9
1.6
nmol/l
21.6
19.9
1.02
220
1619
(3002030) Lymphocytes/100 leukocytes in Blood
358
3047
1.26
3.17
4.2
5.4
%
23.5
26.0
3.23
337
2774
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
55
2.75
3.16
1.3
3.4
%
69.0
57.0
—
7
37
(3006504) Eosinophils/100 leukocytes in Blood
351
2981
1.27
3.16
4.0
5.3
%
2.3
3.0
7.60
334
2722
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
149
1125
1.38
3.13
3.2
2.8
e6/l
2.3
1.9
0.32
93
623
(1002224) Polysomnography panel
7
212
0.33
3.08
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
21
434
0.47
3.02
1.8
2.5
—
15.0
—
0
12
(3002385) Erythrocyte distribution width [Ratio]
488
5446
0.81
2.99
39.3
17.2
%
15.3
13.8
46.09
476
5268
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
67
998
0.65
2.98
12.8
7.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
40
3.02
2.98
1.1
1.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
340
2894
1.26
2.97
4.0
5.2
%
0.6
0.7
1.05
324
2643
(3044889) 12 lead EKG panel
446
5021
0.81
2.95
4.7
4.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
210
0.33
2.94
1.3
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
80
546
1.50
2.91
7.3
6.6
mmol/l
25.5
24.4
1.73
75
508
(3019060) Gas panel - Arterial blood
81
556
1.49
2.87
5.2
4.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
73
1058
0.67
2.85
1.2
1.3
g/l
2.6
2.9
0.66
44
600
(40768793) Breast Pathology biopsy report
10
31
3.25
2.77
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
104
759
1.41
2.69
6.1
3.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
19
4.23
2.68
1.3
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
307
2611
1.25
2.66
3.1
3.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
15
4.69
2.60
1.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
16
4.40
2.47
1.1
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
109
2.04
2.47
3.3
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
292
2496
1.23
2.39
3.6
3.5
e6/l
61.5
127.5
1.86
229
1810
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
77
2.23
2.38
1.1
1.3
e6/l
20943.8
106402.5
0.59
11
49
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
78
2.20
2.32
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
377
0.52
2.25
1.0
1.4
—
48.1
—
0
17
(3024354) Oxygen [Partial pressure] in Venous blood
87
638
1.40
2.22
3.6
2.5
kpa
4.5
4.5
0.04
82
607
(36304419) Bacteria [Presence] in Urine
225
1884
1.25
2.21
3.1
3.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
73
2.21
2.21
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
83
605
1.40
2.20
1.3
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
214
1785
1.25
2.18
1.9
1.7
pmol/l
458.0
17115674.9
1.26
176
1449
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
183
0.38
2.16
1.4
1.9
nmol/l
66.0
42.8
—
7
173
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
358
0.52
2.15
1.4
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
370
3269
1.20
2.14
3.9
5.1
e9/l
1.6
1.8
1.79
317
2828
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
190
1.71
2.12
1.9
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
26
3.09
2.01
1.8
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
186
1544
1.25
1.98
2.3
2.4
e6/l
6.2
4.4
1.98
166
1337
(3000492) Spirometry study
75
549
1.39
1.96
1.4
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
76
560
1.38
1.92
2.1
1.7
nmol/l
377.6
369.1
0.16
71
500
(3051593) INR in Capillary blood by Coagulation assay
0
50
0.00
1.89
0.0
14.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
439
4816
0.85
1.87
4.3
4.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
72
2.10
1.87
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
28
2.87
1.86
1.1
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
54
0.00
1.85
0.0
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
42
619
0.67
1.85
2.5
2.1
ug/g
228.0
159.1
0.79
35
476
(3011397) Hemoglobin [Presence] in Urine by Test strip
137
1678
0.79
1.84
3.1
3.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
340
3019
1.19
1.82
3.9
5.3
%
59.1
58.7
0.19
322
2769
(3006315) Basophils [#/volume] in Blood
360
3215
1.18
1.80
3.9
5.1
e9/l
0.0
0.0
0.42
303
2730
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
246
0.48
1.78
1.5
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
358
3199
1.18
1.77
3.8
5.0
e9/l
0.7
0.6
1.83
302
2710
(3023183) Ammonium ion [Moles/volume] in Plasma
26
154
1.71
1.77
1.2
2.7
umol/l
30.0
34.2
0.34
21
133
(3045788) Cell count panel - Pleural fluid
14
67
2.10
1.76
1.3
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
41
2.45
1.75
1.4
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
109
1355
0.78
1.66
1.5
1.7
mg/l
2.4
1.3
2.68
92
1040
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
15
278
0.53
1.66
1.4
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
90
1.90
1.65
1.4
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
83
1.94
1.65
2.6
2.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
96
1208
0.77
1.62
1.1
1.2
u/ml
1.1
1.8
0.83
31
322
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
134
0.37
1.61
1.2
1.2
u/l
20.2
23.1
—
5
116
(40768800) Prostate Pathology biopsy report
12
56
2.16
1.61
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
157
0.44
1.56
2.3
1.7
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
17
93
1.84
1.52
5.3
6.5
mg/l
11.7
12.1
0.13
17
83
(3021788) Differential panel - Synovial fluid
6
144
0.41
1.52
1.5
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
152
0.46
1.44
1.0
1.2
mmol/l
3.4
4.0
—
7
144
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
16
3.13
1.44
1.0
1.2
%
32.2
33.6
—
5
11
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
52
700
0.73
1.43
1.2
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
326
0.61
1.43
1.2
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
366
3325
1.15
1.42
4.0
5.2
e9/l
0.2
0.2
4.91
313
2877
(40761536) Microorganisms panel - Urine sediment
70
538
1.32
1.41
3.0
3.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
22
134
1.66
1.40
1.6
2.4
%
258.1
199.3
1.87
22
127
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
29
2.42
1.39
4.4
4.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
23
2.62
1.37
1.0
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
175
1.56
1.35
1.3
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
141
1187
1.22
1.35
3.1
2.6
e6/l
1.6
1.1
1.21
85
686
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
39
0.00
1.34
0.0
6.9
—
74.2
—
0
33
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
49
361
1.37
1.30
3.7
3.1
mmol/l
23.5
24.4
0.85
44
316
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
173
0.52
1.30
1.9
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
48
2.09
1.28
2.7
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
35
2.30
1.27
9.4
2.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
101
828
1.24
1.25
1.7
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
36
502
0.71
1.25
2.5
3.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
36
2.23
1.24
1.3
2.8
—
—
—
0
0
(3013512) EKG study
200
2269
0.85
1.23
4.3
4.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
56
1.97
1.22
1.4
3.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
141
0.49
1.21
1.9
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
24
156
1.55
1.21
2.3
3.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
8
38
2.11
1.18
1.0
1.8
u/l
—
112.3
—
0
8
(3021601) Nitrite [Presence] in Urine by Test strip
310
3397
0.88
1.18
5.2
4.9
estimate
0.0
0.0
0.00
67
563
(3017446) Testosterone [Moles/volume] in Serum or Plasma
34
473
0.71
1.17
1.5
2.3
nmol/l
14.8
14.9
0.02
29
417
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
35
0.00
1.15
0.0
1.1
—
1.1
—
0
22
(3035880) pH of Pleural fluid
7
30
2.34
1.12
1.1
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
315
3439
0.88
1.12
3.6
3.7
estimate
0.0
0.0
0.50
66
555
(3019309) Folate [Moles/volume] in Red Blood Cells
199
1760
1.16
1.10
2.0
1.8
nmol/l
1199.1
1171.3
0.16
166
1322
(4034850)
18
280
0.64
1.10
17.7
12.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
163
0.55
1.09
2.7
2.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.4
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
31
431
0.71
1.08
1.1
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
288
3153
0.88
1.07
3.7
4.2
ng/l
32.1
80.0
2.10
236
2375
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
52
1.93
1.06
1.0
1.2
—
—
—
0
0
(4010399)
38
508
0.74
1.05
1.3
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
144
1654
0.85
1.04
3.8
4.0
kg/l
1.0
1.0
0.16
20
254
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
275
0.65
1.03
2.0
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
313
3398
0.89
1.00
3.7
3.6
estimate
0.0
0.0
0.00
67
571
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
131
1.54
1.00
1.4
1.4
—
—
—
0
0
(4094501)
11
188
0.58
0.99
1.2
1.1
—
—
—
0
0
(3020891) Body temperature
45
345
1.32
0.98
4.5
4.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
84
1.68
0.98
1.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
36
1.95
0.97
1.1
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
31
0.00
0.96
0.0
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
22
317
0.69
0.96
1.2
1.8
—
27.1
—
0
9
(3036670) Protein [Mass/volume] in Synovial fluid
0
32
0.00
0.95
0.0
1.1
—
36.6
—
0
18
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.2
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
14
219
0.63
0.91
2.1
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
94
1.60
0.91
1.2
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
395
1.28
0.89
2.3
2.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
29
2.07
0.89
1.2
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
71
1.70
0.89
1.6
1.6
u/ml
360.3
59.4
0.37
12
66
(3022217) INR in Platelet poor plasma by Coagulation assay
113
1301
0.85
0.86
21.9
29.3
inr
1.3
1.5
1.32
20
176
(40761535) Cells panel - Urine sediment
54
664
0.80
0.83
2.8
3.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
50
620
0.80
0.82
1.6
1.8
%
1.6
1.6
0.01
42
515
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
11
177
0.62
0.82
1.4
1.4
g/l
1.1
1.1
0.15
11
168
(3027923) C peptide [Moles/volume] in Serum or Plasma
6
32
1.88
0.82
1.7
1.5
nmol/l
0.7
1.2
—
6
21
(3000034) Microalbumin [Mass/volume] in Urine
13
81
1.61
0.81
1.6
3.0
mg/l
22.6
34.0
—
8
66
(3026008) Bacteria identified in Urine by Culture
236
2161
1.12
0.79
2.9
3.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
36
462
0.77
0.79
1.5
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
24
0.00
0.79
0.0
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
1783.8
—
0
24
(3003129) Base excess in Capillary blood by calculation
0
25
0.00
0.79
0.0
1.3
—
0.9
—
0
25
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
66
1.67
0.79
1.1
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
11
172
0.64
0.74
1.4
1.4
g/l
0.2
0.2
0.07
11
165
(3044927) Protein electrophoresis panel - Urine
6
107
0.56
0.72
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
276
0.72
0.72
1.3
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
57
1.58
0.71
1.4
1.6
%
8.5
10.5
—
9
57
(3044242) Glucose [Moles/volume] in Arterial blood
9
57
1.58
0.71
2.4
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
35
274
1.29
0.70
2.5
1.8
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
9
58
1.56
0.70
1.1
1.2
mmol/l
42.0
36.0
—
9
52
(1761482) Bacteria [#/volume] in Urine by Culture
29
222
1.31
0.68
5.0
4.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
29
374
0.77
0.68
2.2
3.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
128
0.62
0.64
1.4
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
13
87
1.50
0.63
1.1
1.9
%
84.6
90.2
0.72
13
87
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
289
2707
1.09
0.63
2.5
2.2
nmol/l
73.8
77.7
1.61
267
2323
(3006270) Folate [Moles/volume] in Blood
12
79
1.52
0.62
1.0
1.3
nmol/l
360.6
352.2
0.07
12
65
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
143
1292
1.12
0.62
1.7
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
103
0.58
0.62
3.3
3.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
49
1.64
0.62
1.4
2.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
30
1.67
0.61
1.2
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
30
1.67
0.61
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
137
0.65
0.61
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
104
923
1.14
0.60
1.7
1.8
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
80
1.51
0.60
1.2
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
1.1
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
131
1.38
0.59
1.2
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
81
1.49
0.57
1.2
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
40
483
0.82
0.56
2.2
3.5
mmol/l
3.6
1.9
1.04
26
347
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
104
929
1.13
0.56
1.7
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
75
855
0.87
0.55
2.4
2.5
ug/l
4.8
7.2
1.00
59
730
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
125
0.64
0.54
1.0
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
142
1.34
0.54
1.2
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
261
0.76
0.54
1.3
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
169
1.31
0.53
3.4
2.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
11
158
0.69
0.53
1.2
2.0
mg/l
28.4
12.0
0.44
11
146
(3051611) Lipemic interference index of Serum or Plasma
9
63
1.43
0.52
8.7
2.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
18
136
1.33
0.49
1.3
1.4
mmol/l
60.2
63.2
0.13
13
106
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
108
0.65
0.48
1.0
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
311
0.80
0.48
1.1
1.2
iu/ml
115.8
134.4
—
6
125
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
68
1.48
0.47
1.9
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
232
0.77
0.46
1.1
1.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
82
0.61
0.46
1.0
1.5
g/l
0.9
0.9
—
5
66
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
84
0.59
0.45
1.0
1.0
g/l
1.7
1.5
—
5
73
(4024509)
8
58
1.38
0.41
1.9
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.3
—
0.8
—
0
5
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
48
550
0.87
0.41
1.3
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
59
1.36
0.41
1.5
3.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
79
1.40
0.41
1.2
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
315
1.18
0.40
1.4
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
150
1.27
0.40
1.8
2.5
%
12.2
16.2
—
7
77
(3002523) Influenza virus A Ag [Presence] in Specimen
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
26
214
1.22
0.39
5.0
3.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
10
71
1.41
0.39
1.1
1.2
iu/l
50.1
23.2
—
10
60
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
19
0.00
0.39
0.0
1.3
—
0.2
—
0
19
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
113
0.71
0.37
3.3
2.5
—
—
—
0
0
(3004451) EKG impression Narrative
5
37
1.35
0.37
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
90
1.34
0.36
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
90
1.34
0.36
1.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
126
0.71
0.35
1.1
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
253
2647
0.94
0.35
4.0
3.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
449
4623
0.95
0.35
4.5
4.5
e6/l
8257.9
2658.4
—
9
96
(3021901) Oxygen saturation in Capillary blood
19
154
1.24
0.34
1.9
2.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
87
0.69
0.33
1.5
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
12
154
0.78
0.32
1.3
1.4
nmol/l
0.7
0.8
0.16
12
125
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
92
1.31
0.32
1.0
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
48
428
1.13
0.31
3.2
3.1
e9/l
4.9
4.0
0.53
38
302
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
53
1.32
0.31
1.3
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
325
0.86
0.30
1.2
1.4
g/l
7.4
7.4
0.07
19
232
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
325
0.86
0.30
1.2
1.4
g/l
3.5
3.9
1.39
18
224
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
325
0.86
0.30
1.2
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
102
1.28
0.30
1.2
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
239
0.83
0.30
1.4
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
13
163
0.80
0.29
3.2
2.4
mg/l
2.1
1.7
0.45
13
141
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
151
0.79
0.28
1.2
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
299
0.87
0.26
1.2
1.5
g/l
3.1
3.1
0.07
18
227
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
73
0.68
0.26
1.4
1.2
mmol/l
7.1
7.9
—
5
45
(3045424) Erythrocytes [Presence] in Urine
6
83
0.72
0.24
1.3
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
65
601
1.09
0.23
1.4
1.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
39
1.28
0.23
1.2
1.2
u/l
13.8
10.7
—
5
34
(3032773) Endomysium IgG Ab [Titer] in Serum
5
40
1.25
0.22
1.4
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
1.2
u/l
11.2
16.5
—
5
36
(3016228) CD19 cells/100 cells in Blood
0
11
0.00
0.21
0.0
1.5
—
4.5
—
0
11
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.6
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.0
—
8.0
—
0
5
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.7
—
6.5
—
0
12
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
12
0.00
0.21
0.0
4.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
44
402
1.10
0.21
1.1
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
5.0
—
0
5
(3024471) HLA-A [Type]
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
16.5
—
0
14
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.3
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.3
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
185
0.86
0.18
1.1
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
22
246
0.89
0.16
1.8
2.5
g/l
0.3
0.2
—
10
92
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
52
486
1.07
0.16
1.9
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
73
1.10
0.15
1.1
1.4
nmol/l
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
236
1.10
0.15
3.3
3.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
275
1.09
0.14
1.1
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
100
0.80
0.13
1.1
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
316
1.08
0.12
1.8
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
59
561
1.05
0.12
4.3
3.4
ng/l
109.4
92.3
0.52
49
475
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
189
0.90
0.12
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
114
1.14
0.12
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
86
1.16
0.11
1.2
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
125
0.88
0.10
1.2
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
49
467
1.05
0.10
1.3
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
291
1.07
0.09
1.6
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
84
813
1.04
0.09
2.4
3.2
ng/l
259.5
281.5
0.17
78
758
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(44790047)
7
64
1.09
0.08
1.1
1.3
—
—
—
0
0
(44790049)
7
64
1.09
0.08
1.1
1.3
—
—
—
0
0
(44806118)
7
64
1.09
0.08
1.1
1.3
—
—
—
0
0
(44790048)
7
64
1.09
0.08
1.1
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
67
1.05
0.08
1.0
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
164
0.91
0.08
1.5
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
68
1.03
0.08
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
410
4062
1.02
0.07
3.4
3.0
u/l
77.7
51.9
2.00
381
3678
(3026389) Candida sp identified in Specimen by Organism specific culture
8
75
1.07
0.07
1.4
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
204
0.93
0.07
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
87
1.03
0.07
1.3
2.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
19
177
1.07
0.06
1.9
2.1
g/l
110.5
132.4
2.10
13
128
(3000330) Specific gravity of Urine by Test strip
39
406
0.96
0.06
6.7
3.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
292
2891
1.01
0.06
13.1
8.7
e9/l
0.0
0.0
0.08
229
2336
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
182
0.93
0.05
4.1
3.5
mg/l
62.3
27.4
1.37
11
126
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
202
0.94
0.05
1.2
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
191
1889
1.01
0.04
3.3
3.9
estimate
0.0
0.0
0.50
54
531
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
56
573
0.98
0.04
5.8
2.4
ml/min/173m2
59.6
62.7
0.24
23
231
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
102
1.08
0.03
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
160
1588
1.01
0.02
3.3
4.2
ng/l
725.8
432.6
0.23
132
1354
(3041096) Erythrocytes [Presence] in Urine by Automated
177
1759
1.01
0.02
3.7
3.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
328
3287
1.00
0.00
2.4
2.1
pmol/l
84.6
92.4
3.17
234
1713
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
50
494
1.01
0.00
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
192
0.99
0.00
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
192
0.99
0.00
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
201
0.99
0.00
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
72
718
1.00
0.00
3.8
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
78
777
1.00
0.00
1.5
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
145
1.03
0.00
1.3
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
69
1.01
0.00
1.0
2.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
89
1.01
0.00
1.3
2.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
1.8
—
0
6
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
80
1.00
0.00
1.1
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
87
0.92
0.00
1.4
2.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
19.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
88
0.91
0.00
1.1
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
87
0.92
0.00
2.4
3.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
89
0.90
0.00
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
89
1.01
0.00
1.3
2.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
87
0.92
0.00
1.4
1.6
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
104.4
—
0
5
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
13.4
—
0
5
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.5
—
2.0
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
23.6
—
0
6
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
5
57
0.88
0.00
1.0
1.0
mg/l
322.2
278.6
—
5
50
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
16.2
—
0
5
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_STOMACH_ADENO_EXALLC – Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).